American College of Cardiology
Avatar

Trastuzumab Cardiotoxicity in mBC: When to Restart HER2 Therapy? Will Stopping Trastuzumab for 1 or 2 Administrations Impact the Patient Outcome?

By American College of Cardiology FEATURING Srilakshmi Vallabhaneni, Giuseppe Curigliano, Daniel Lenihan, Bonnie Ky
By American College of Cardiology FEATURING Srilakshmi Vallabhaneni, Giuseppe Curigliano, Daniel Lenihan, Bonnie Ky
38 views
September 21, 2020
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
53:42
PleXus Communications

Managing Women's Health in Menopause: Evolving Approaches for t…

Feat. J. Simon, T. Iyer, A. Fiffick, M. Minkin
10:04
University of Colorado Department of Medicine

Cardiotoxicity in Breast Cancer – Case Discussion

Feat. L. Kondapalli
11:43
University of Colorado Department of Medicine

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

Feat. L. Kondapalli
10:39
University of Colorado Department of Medicine

Cardio-Oncology: Definitions and Scope

Feat. L. Kondapalli
23:02
Cleveland Clinic Taussig Cancer Institute

Pulmonary Complications of Checkpoint Inhibitor Therapy

Feat. M. Smith
20:25
Andrew Hahn

ADT for Prostate Cancer and Cardiovascular Health Considerations

07:01
Total Health

Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclin…

Feat. I. Rhea
02:52
University of Colorado Department of Medicine

Cardiotoxicity in RCC – Case Discussion

Feat. L. Kondapalli
07:14
University of Colorado Department of Medicine

Cardiotoxicity in Melanoma – Case Discussion

Feat. L. Kondapalli
04:43
Total Health

Cardiac Disease in Breast Cancer: Background & Risk Factors

Feat. I. Rhea
10:49
Monia Marchetti

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

15:54
Przemyslaw Twardowski

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

19:28
OncoAlert

Cutaneous Toxicity in Oncology: Mechanism and Management

Feat. P. Bhargava
52:19
UNC Lineberger Comprehensive Cancer Center

CAR-T 101: Overview of CAR-T Therapy and Management of Toxicities

Feat. M. Mcelfresh
22:38
Scripps Health

Clinical Presentation of Amyloidosis: Who to Suspect? - a 2022 Update

Feat. R. Mohan
41:34
MedNews Week

Cancer and Cardiovascular Disease: The Conjoined Twins

Feat. R. Moudgil
08:40
PrecisCa

Managing Common Toxicities From CDK4/6i

Feat. E. Shonkwiler
21:26
NYU Langone

Common TKI Toxicity Management in 2L HCC Treatment

Feat. J. Wu
03:48
GRACE

NSCLC Trials for Patients With Actionable Mutations and the Importan…

Feat. J. Rotow, P. Iyengar, T. Leal
17:19
Kate Young

Optimal Toxicity Management in mRCC